https://www.selleckchem.com/pr....oducts/a-d-glucose-a
These results show that ATF treatment targeting the HBV core protein promoter has an antiviral effect and inhibits HBV infection in host cells. These results further suggest that the design of new artificial transcription factors may be valuable antiviral therapies to treat HBV patients. © 2020 by the Association of Clinical Scientists, Inc.The aim of the present study is to investigate the effect of cyclopamine, a hedgehog signaling pathway inhibitor, on adjuvant arthritis (AA), rat articular chondrocyte viability, and pa
Like
Comment
Share
